These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23305561)

  • 1. In silico physicochemical parameter predictions.
    Wenlock MC; Barton P
    Mol Pharm; 2013 Apr; 10(4):1224-35. PubMed ID: 23305561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development?
    Kuentz M; Imanidis G
    Eur J Pharm Sci; 2013 Feb; 48(3):554-62. PubMed ID: 23262058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity.
    Hill AP; Young RJ
    Drug Discov Today; 2010 Aug; 15(15-16):648-55. PubMed ID: 20570751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prediction of ionization constants of drugs.
    Lee PH; Ayyampalayam SN; Carreira LA; Shalaeva M; Bhattachar S; Coselmon R; Poole S; Gifford E; Lombardo F
    Mol Pharm; 2007; 4(4):498-512. PubMed ID: 17629304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
    Tian F; Yang L; Lv F; Yang Q; Zhou P
    Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond profiling: using ADMET models to guide decisions.
    Segall M; Champness E; Obrezanova O; Leeding C
    Chem Biodivers; 2009 Nov; 6(11):2144-51. PubMed ID: 19937845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates.
    Li D; Chen L; Li Y; Tian S; Sun H; Hou T
    Mol Pharm; 2014 Mar; 11(3):716-26. PubMed ID: 24499501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular topology as a novel approach for drug discovery.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorination Patterning: A Study of Structural Motifs That Impact Physicochemical Properties of Relevance to Drug Discovery.
    Huchet QA; Kuhn B; Wagner B; Kratochwil NA; Fischer H; Kansy M; Zimmerli D; Carreira EM; Müller K
    J Med Chem; 2015 Nov; 58(22):9041-60. PubMed ID: 26523333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Cheminformatics in Drug Discovery.
    Lawless MS; Waldman M; Fraczkiewicz R; Clark RD
    Handb Exp Pharmacol; 2016; 232():139-68. PubMed ID: 26318607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico prediction of aqueous solubility: a multimodel protocol based on chemical similarity.
    Chevillard F; Lagorce D; Reynès C; Villoutreix BO; Vayer P; Miteva MA
    Mol Pharm; 2012 Nov; 9(11):3127-35. PubMed ID: 23072744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Physicochemical Measurements to Influence Better Compound Design.
    Bunally SB; Luscombe CN; Young RJ
    SLAS Discov; 2019 Sep; 24(8):791-801. PubMed ID: 31429385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational prediction of drug solubility in water-based systems: Qualitative and quantitative approaches used in the current drug discovery and development setting.
    Bergström CAS; Larsson P
    Int J Pharm; 2018 Apr; 540(1-2):185-193. PubMed ID: 29421301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale prediction of drug-target interactions using protein sequences and drug topological structures.
    Cao DS; Liu S; Xu QS; Lu HM; Huang JH; Hu QN; Liang YZ
    Anal Chim Acta; 2012 Nov; 752():1-10. PubMed ID: 23101647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico estimation of basic activity-relevant parameters for a set of drug absorption promoters.
    Bak A; Kozik V; Smolinski A; Jampilek J
    SAR QSAR Environ Res; 2017 Jun; 28(6):427-449. PubMed ID: 28573881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications and limitations of in silico models in drug discovery.
    Sacan A; Ekins S; Kortagere S
    Methods Mol Biol; 2012; 910():87-124. PubMed ID: 22821594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.